AlzChem Group AG
XETRA:ACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AlzChem Group AG
XETRA:ACT
|
DE |
|
Ponce Financial Group Inc
NASDAQ:PDLB
|
US |
|
L
|
Lowell Farms Inc
OTC:LOWLF
|
US |
|
Koss Corp
NASDAQ:KOSS
|
US |
Wall Street
Price Targets
ACT Price Targets Summary
AlzChem Group AG
According to Wall Street analysts, the average 1-year price target for
ACT
is 189.94 EUR
with a low forecast of 176.75 EUR and a high forecast of 206.85 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACT's stock price target?
Price Target
189.94
EUR
According to Wall Street analysts, the average 1-year price target for
ACT
is 189.94 EUR
with a low forecast of 176.75 EUR and a high forecast of 206.85 EUR.
What is AlzChem Group AG's Revenue forecast?
Projected CAGR
13%
For the last 6 years the
compound annual growth rate for
AlzChem Group AG's revenue is
7%.
The projected
CAGR
for the next 3 years is
13%.
What is AlzChem Group AG's Operating Income forecast?
Projected CAGR
18%
For the last 6 years the
compound annual growth rate for
AlzChem Group AG's operating income is
21%.
The projected
CAGR
for the next 3 years is
18%.
What is AlzChem Group AG's Net Income forecast?
Projected CAGR
17%
For the last 6 years the
compound annual growth rate for
AlzChem Group AG's net income is
23%.
The projected
CAGR
for the next 3 years is
17%.
